SOMNARUS
Somnarus Inc. is a medical diagnostic company whose innovative products address the significant unmet need of patients with obstructive sleep apnea. With 50 million Americans at risk for sleep apnea and the average medical insurance reimbursement rate of $160 per test, Somnarus is entering the market, whose potential is estimated at $8B. Only SomnaPatch™ product combines accuracy and the ease-of-use with guaranteed medical insurance reimbursement and the convenience of in-home delivery.
SOMNARUS
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2013-01-01
Address:
Mountain View, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
149.8 K USD
Similar Organizations
Implex
Implex a company whose products can change the way orthopedic surgeons treat the disease of or injury to the human musculoskeletal system.
Investors List
National Science Foundation
National Science Foundation investment in Grant - Somnarus
MedTech Innovator
MedTech Innovator investment in Grant - Somnarus